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Background: The optimal anti-reﬂux procedure after Heller cardiomyotomy for oesophageal achalasia
remains unclear. The most commonly used procedure is the anterior partial fundoplication according to
Dor, although during recent years the posterior counterpart (Toupet) has become popular.
Methods: Patients with newly diagnosed achalasia and referred for cardiomyotomy were randomised to
receive either an anterior or partial posterior fundoplication following a classical cardiomyotomy. The
effect of surgery was assessed during the ﬁrst postoperative year by Eckardt scores, EORTC QLQ-OES18
scores and HRQL questionnaires. Timed barium oesophagogram (TBO) and ambulatory 24-h pH moni-
toring were performed to determine oesophageal emptying and the degree of reﬂux control, respectively.
Results: Forty-two patients were randomised into Dor (n ¼ 20) and Toupet (n ¼ 22) groups. Eckardt
scores improved dramatically with both procedures, but the EORTC QLQ-OES18 (functional scales) scores
revealed signiﬁcantly better relative improvements in the Toupet group compared to the Dor repair
(P ¼ 0.044). Corresponding advantages in favour of Toupet were observed postoperatively in the per-
centage of oesophageal emptying at TBO (P ¼ 0.011 in height and P ¼ 0.018 in area), an effect not
observed in the Dor group. There were no other signiﬁcant differences recorded between the study
groups concerning HRQL evaluations and objective assessment of gastro-oesophageal acid reﬂux.
Conclusions: A partial posterior fundoplication after cardiomyotomy seems to achieve more improve-
ment in oesophageal emptying and EORTC QLQ-OES18 functional scale scores than the anterior fundo-
plication. Otherwise no differences between the two anti-reﬂux repairs were noted.
Trial registration number: ClinicalTrials.gov Identiﬁer: NCT01933373.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.l Gastroenterology, Gastro-
holm, Sweden.
by Elsevier Ltd. All rights reserved1. Introduction
Achalasia of the oesophagus is a rare primary motility disorder
characterised by aperistalsis of the oesophageal body and failure of
the lower oesophageal sphincter (LOS) to relax in response to
swallowing. This results in dysphagia, regurgitation, weight loss,.
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by eliminating the outﬂow resistance caused by the hypertensive
and non-relaxing LOS. The results of pharmacological treatments
for achalasia including injection of botulinum toxin have been
generally disappointing and are only recommended to patients
unﬁt for interventions under general anaesthesia [1e3]. According
to the available evidence, pneumatic dilation of the LOS or a Heller
cardiomyotomy constitutes standard care for the majority of pa-
tients with achalasia [4,5].
Themajor downside of cardiomyotomy is the substantial gastro-
oesophageal reﬂux that follows a complete division of the entire
LOS, including the gastric sling ﬁbres. Therefore, a fundoplication to
prevent debilitating reﬂux is required [6]. Available data suggest
that a total fundoplication should be avoided, and instead a partial
wrap of the oesophagus either dorsally (Toupet) or anteriorly (Dor)
is generally recommended [7]. A potential disadvantage of the
posterior approach is angulation of the gastro-oesophageal junc-
tion and the eventual obstruction of bolus passage. Advocates of the
Dor procedure argue that disruption of the peri-oesophageal liga-
ment and attachments during the posterior procedure might also
induce reﬂux [8]. However, by extrapolating ﬁndings in gastro-
oesophageal reﬂux disease (GORD) patients, the posterior partial
fundoplication would better function as an anti-reﬂux repair [9].
The low incidence of achalasia makes it demanding and chal-
lenging to pursue randomised clinical trials in these patients.
Accordingly, the evidence regarding differences between anterior
and posterior fundoplication after cardiomyotomy is mainly based
on prospective or retrospective single-institution series. Interest-
ingly, data from a recent randomised trial showed no signiﬁcant
differences between the fundoplication alternatives [8]. Moreover,
in a meta-regression analysis published thereafter, incorporating
also non-randomised trials, more re-interventions were recorded
after an anterior fundoplication [10].
Performing a complete cardiomyotomy in achalasia patients
mandates the surgeon to follow a delicate balance between pre-
venting reﬂux and maintaining the function and anatomy of the
diaphragmatic hiatal region.
The aim of the present study was therefore to collect comple-
mentary data on the symptomatic and objective outcomes after
Toupet and Dor fundoplications within a randomised clinical trial.2. Patients and methods
The study was run as a prospective, randomised trial of patients
with newly diagnosed achalasia. The patients were managed and
operated on at Ersta Hospital Stockholm and Karolinska University
Hospital, Huddinge.
The Local Ethics Committee approved the study and a signed
informed consent was obtained from all patients. The study was
registered in ClinicalTrials.gov with the register number of
NCT01933373.2.1. Inclusion/exclusion criteria
Inclusion criteria were symptoms rated as >3 by the Eckardt
score [11], a diagnostic oesophageal manometry that demonstrated
partial or complete absence of LOS relaxation as a response to
repeated water swallows, and absence of oesophageal body peri-
stalsis. Exclusion criteria were other severe illnesses liable to pre-
vent anaesthesia and/or surgery, pseudo-achalasia due to
oesophageal motility disorders associated with malignancy with
extension into the lower oesophagus, or other factors expected to
inhibit data retrieval.2.2. Registration and randomisation of patients and blinding
Included patients were randomly assigned to treatment groups
using computer-generated permutated blocks of random sizes. At
inclusion each patient received a numeric code, and was thereafter
blinded to the reconstructive procedure given, as were the care
providers and assessors. Only the principal investigator (BH) could
access patients through the codes. Patient data were collected
separately from regular medical records in predeﬁned case record
forms.
2.3. 24-h pH monitoring
The pH recordings were performed using an antimony mea-
surement electrode with a built-in reference electrode. The mea-
surement electrode was placed 5 cm proximal to the LOS, as
identiﬁed by the previous manometric examination. Patients were
instructed to avoid acidic foods and drinks and to abstain from
alcohol during the recording period. Technically unsatisfactory re-
cordings, or recordings shorter than 18 h, were not included in the
analysis.
The results of oesophageal pH monitoring were reported as
percent time pH< 4.0 for the total duration of the recording, and for
the time spent in upright and in supine positions, respectively. The
total numbers of reﬂux episodes were also noted.
2.4. Timed barium oesophagogram (TBO)
Barium column height and width during TBO were measured at
1, 2, and 5 min after ingestion of 250 ml of low-density barium
sulphate suspension according to standardised protocols [12].
Accordingly, a single radiologist (SG) calculated the area of the
oesophageal barium column using the Sectra IDS7/DX (Sectra Imtec
AB, Link€oping, Sweden). The changes in area and height from the
1 mine5 min ﬁlm formed the basis for analysing the degree of
oesophageal emptying (“Percentage of oesophageal emptying”).
The rate of reduction in the barium height or area from the pre-
operative to the postoperative study was calculated to evaluate the
treatment effect (“Reduction rate”).
2.5. Symptom assessments
Symptoms were measured using the HRQL questionnaire [13]
and the Eckardt score [11]. Patients with symptoms rated as >3
by the Eckardt score at 12 months after operation were regarded as
recurrences or treatment failures. In cases where the patient had
experienced recurrent symptoms or relapse and appropriate
treatment had been given, the symptoms proceeding additional
treatment was analysed. Pre- and postoperative health-related
quality of life was measured by the validated EORTC QLQ-OES18
form, an oesophageal cancer-speciﬁc module. This instrument
consists of “functional scales” assessing the degree of dysphagia
and “symptom scales” evaluating symptoms associatedwith eating,
reﬂux, pain, swallowing, dry mouth, taste, coughing, and talking
[14,15].
2.6. Surgical technique
In open surgery, an upper midline incision was made. For lap-
aroscopy, patients were placed in the French position and ﬁve
trocars were inserted in the upper abdominal region. In all patients,
the phrenico-oesophageal ligament was then opened and the distal
oesophagus was mobilised on the lateral and anterior sides.
Myotomy was performed anteriorly with a length of at least 6 cm,
extending no less than 1 cm below the gastro-oesophageal
Fig. 1. CONSORT Flow diagram. *One patient desired to have pneumatic dilatation after randomisation and refused surgery. yThere were no patients who were lost to follow up or
discontinued intervention, but data were not available from all the patients. Analyses were performed using all available data. **Number of the patients analysed in repeated
measures.
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divided only if the fundus was insufﬁciently mobile and the fundus
was then sutured to each end of themyotomy and to the right hiatal
crus using non-absorbable sutures. In the Toupet group, the
mobilised funduswas pulled posteriorly to the oesophagus creatingTable 1
Patient characteristics.
Dor (n ¼ 19) Toupet (n ¼ 22) P value
General characteristics
Age (years) 45 (19e82) 44 (20e76) 0.666
Sex (male/female) 8/11 11/11 0.756
BMI (kg/m2) 22.9 ± 4.2 23.8 ± 3.3 0.879
Previous treatment
Medical treatment (yes/no) 2/17 0/21 0.219
Botox (yes/no) 0/19 1/20 1.000
Dilatation (yes/no) 1/17 1/20 1.000
BMI, Body mass index. Data are presented as means ± SD, median (range) or the
number of patients. A ManneWhitney U test was used to test the equality between
the two medians of the variables. The Fisher's exact test was used to test the in-
dependence between the two groups.a wrap that was sutured to the right and left edges of the myotomy
using non-absorbable sutures. Finally, the posterior aspect of the
wrap was sutured to the diaphragmatic crura.Table 2
Operative data.
Dor (n ¼ 19) Toupet (n ¼ 22) P value
Operation time (min) 103 (83e151) 95 (83e135) 0.537
Blood loss (ml) 0 (0e20) 0 (0e20) 0.758
Postoperative complication
Grade IIIb
Leakage 0 1 0.941
Grade II
Pneumonia 0 1 0.941
Postoperative hospital stay (days) 2 (1e12) 2 (1e16) 0.743
Sick leave (days) 14 (0e21) 14 (0e30) 0.789
Data are presented as median (range) or the number of patients. The severity of
complications was graded using the ClavieneDindo classiﬁcation of surgical com-
plications. ManneWhitney U tests were used to test the equality between the two
medians of the variables. The Fisher's exact test was used to test the independence
between the two groups.
Table 3
Pre- and postoperative Eckardt score.











0, None 5 8 0.288 11 12 0.487
1, <5 kg 6 3 0 2
2, 5e10 kg 1 5 0 0
3, >10 kg 3 3 0 0
Dysphagia
0, None 1 1 0.200 5 5 0.846
1, Occasional 0 3 2 5
2, Daily 5 2 2 2
3, Each meal 9 13 2 2
Retrosternal pain
0, None 2 2 0.443 6 7 0.369
1, Occasional 5 10 3 6
2, Daily 6 3 2 0
3, Each meal 2 4 0 1
Regurgitation
0, None 2 5 0.802 10 11 0.604
1, Occasional 4 5 1 3
2, Daily 3 4 0 0
3, Each meal 6 5 0 0
Data are presented as the number of patients. The Fisher's exact test was used to test
the independence between the two groups.
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The primary endpoint in the study was postoperative oeso-
phageal acid exposure at one year postoperatively. Based on pre-
vious studies of partial posterior and anterior fundoplications in
GORD patients, we estimated that a partial posterior fundoplication
would result in a total time oesophageal pH < 4 of 2% [9,16]. To
detect an increase in acid exposure time to 5% after partial anterior
fundoplication, it was calculated that 20 patients would have to be
randomised into each arm, (P < 0.050) with a power of 0.80.
2.8. Statistical analysis
The ManneWhitney U test was used to test the equality of
medians between the groups for each variable. The Fisher's exact
test was used to test the independence between groups. A generalFig. 2. Time course of Eckardt scores from baseline and during the postoperative follow up
values are also given. The bottom and top of the box are the ﬁrst and third quartiles, and th
and maximum of all of the data. Data in parenthesis are number of the patients analysed.linear model (two-way repeated measures ANOVA) was used to
analyse repeated measures. A P value <0.05 was considered sta-
tistically signiﬁcant. All analyses were performed on the per-
protocol set, using SPSS version 11.0 (SPSS, Chicago, IL, USA).
3. Results
From September 2005 to June 2011, a total of 42 patients con-
sented to participate in the study andwere accordingly randomised
(20 into the Dor arm and 22 to have a Toupet). The enrolment
ended in June 2011 when sufﬁcient number of patients had been
included and the study ended in June 2012 when the follow-up of
the last patient was completed. One patient allocated to a Dor
fundoplication, ultimately decided to have pneumatic dilatation
after randomisation, thus refusing surgery and was excluded from
the trial. Therefore, the study analyses were based on 41 rando-
mised patients (Dor, n ¼ 19; Toupet, n ¼ 22). For details of the
enrolment procedure, see Fig. 1.
3.1. Preoperative and perioperative data
All but one of the Heller myotomies was performed by lapa-
roscopy. As seen in Tables 1 and 3, there were no differences in
patient characteristics or symptom severity between the study
groups preoperatively, nor were differences observed in operation
time or estimated blood loss (Table 2). The postoperative course
was basically uneventful after both procedures, although one pa-
tient in the Toupet group developed a leakage from a perforation in
the myotomy that was sealed by a covered self-expanding metal
stent.
3.2. Eckardt score
As a response to therapy, signiﬁcant improvements were
observed in repeated measures of the Eckardt score in the Dor
group (P < 0.001) as well as in the Toupet group (P < 0.001, Fig. 2).
We were unable to reveal a difference in the Eckardt score at any
time point neither between the groups (Table 3) nor in the
magnitude of improvement (Fig. 2). According to the Eckardt score,
1 out of 11 patients (9.1%) in the Dor group and 2 out of the 14
patients (14.3%) in the Toupet group had recurrences or treatment
failures 12 months after operation (P ¼ 1.000).after cardiomyotomy and either Toupet or Dor fundoplication. The corresponding P-
e band inside the box is the median. The ends of the whiskers represent the minimum
Fig. 3. Time course of EORTC QLQ-OES18 scores from baseline and during the postoperative follow up after cardiomyotomy and either Toupet or Dor fundoplication. (a) Functional
scale between the groups at any time point. (b) Symptom scale in the two groups at any time point. The corresponding P-values are shown. The bottom and top of each box
represent the ﬁrst and third quartiles, respectively, and the horizontal band inside the box represents the median. The ends of the whiskers represent the minimum and maximum
of all data points. Data in parenthesis are number of the patients analysed.
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Signiﬁcant improvements were also observed in repeated
measures of functional scales of the QLQ-OES18 both in the Dor
(P ¼ 0.022) and Toupet groups (P < 0.001, Fig. 3). There were noFig. 4. Time course of HRQL scores in achalasia patients before and after cardiomyotomy
bottom and top of each box represent the ﬁrst and third quartiles, respectively, and the hor
the minimum and maximum of all data points. Data in parenthesis are number of the patisigniﬁcant differences between the groups, at any time point after
surgery, in neither of these scales. However, the improvement after
surgery was signiﬁcantly larger in the Toupet group than in the Dor
group when the functional scales (P ¼ 0.044) were compared,
although no corresponding difference could be noted in theand either Toupet or Dor fundoplication. The corresponding P-values are shown. The
izontal band inside the box represents the median. The ends of the whiskers represent
ents analysed.
Fig. 5. Percentage of oesophageal emptying (%) ¼ (1  height or area 5 min after
ingestion/height or area 1 min after ingestion)*100(%). The corresponding P-values are
shown. The bottom and top of each box represent the ﬁrst and third quartiles,
respectively, and the horizontal band inside the box represents the median. The ends
of the whiskers represent the minimum and maximum. Data in parenthesis are
number of the patients analysed.
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comparing the two reﬂux items within the QLQ-OES18 (“heart-
burn” and “acid or bile coming up to the mouth”), we could not
demonstrate signiﬁcant differences between the two groups at any
time point (data not shown).
3.4. HRQL
HRQL scores at 4 weeks, 6 months, and 12 months after the
operations were similar across the groups. There was no signiﬁcant
difference between the groups at any time point (Fig. 4). Signiﬁcant
improvements were observed in repeated measures in the Dor
group (P ¼ 0.001) and in the Toupet group (P < 0.001), respectively,
while no signiﬁcant difference was observed in the magnitude of
improvements between the two groups (P ¼ 0.359).3.5. Endoscopy
Postoperative endoscopy was performed 12 months after sur-
gery in 17 patients (7 in the Dor group and 10 in the Toupet group).
Apart from one patient in the Toupet group who had LA grade A
oesophagitis, no signs of gastro-oesophageal reﬂux could be found
in any of the patients.
3.6. Timed barium oesophagogram (TBO)
Statistically signiﬁcant improvements after the operation were
observed in percentage of the oesophageal emptying both in height
(P ¼ 0.011) and area (P ¼ 0.018) in those having a Toupet fundo-
plication (Fig. 5). However, no signiﬁcant improvement in height
(P¼ 0.147) or area (P¼ 0.420) was found in those patients allocated
to a Dor fundoplication (Fig. 5). However, when the magnitude of
the improvements were compared no differences in height
(P ¼ 0.072) or area (P ¼ 0.175) were recorded between the groups
(Fig. 5). There was also no signiﬁcant difference in the reduction
rate at any time point (Fig. 6).
3.7. 24-h pH monitoring
Postoperative ambulatory pH data were obtained from 24 pa-
tients. Median interval between surgery and postoperative pH
monitoring was 189 days (range; 159e371). We found no signiﬁ-
cant differences in neither median % total time with pH < 4 be-
tween the groups nor when acid reﬂuxwas related to body position
(upright or supine) (Table 4). Similarly, no differences between the
groups were observed in the number of reﬂux episodes represented
by total, upright and supine positions (Table 4). Abnormal acid
reﬂux, deﬁned as the patient with more than 4% total time with
pH < 4, was observed in 2 patients in the Dor group and 5 patients
in the Toupet group (Table 4).
4. Discussion
The present study aimed to determine the efﬁcacy of a partial
fundus wrap in preventing signiﬁcant gastro-oesophageal reﬂux
after cardiomyotomy in achalasia patients. Comparing ambulatory
24-h pH variables, recorded about 6 months after a Toupet (pos-
terior) or a Dor (anterior) wrap, revealed no differences between
the groups. These data suggest that the partial anterior wrap
equally well controls reﬂux after myotomy compared to the partial
posterior fundoplication. Apparently these ﬁndings in achalasia
patients do deviate to a certain degree from the published experi-
ences in GORD patients [9].
Another important ﬁnding of the present study was the prompt
improvement in TBO variables after a Toupet fundoplication, while
a corresponding effect in those patients having a Dor reconstruc-
tion was not equally apparent. Previous studies of TBO as a surro-
gate marker of the functionaleclinical outcome after
cardiomyotomy indicate that these operations induce changes in
these markers that relate well to the clinical course [17,18]. More-
over, Vaezi et al. [19] reported that patients with poor oesophageal
emptying at the TBO after pneumatic dilatation, soon returnedwith
incomplete symptom relief and required complementary treat-
ment within a year. Previous studies have also used the criterion of
“50% or more reduction in post-treatment height compared to pre-
treatment height on 5-min ﬁlms” to deﬁne TBO response. This is
possibly due to the reported better reproducibility of the static TBO
variables such as height and width compared to the percentage
emptying calculated using the area or height of the barium column
[19,20]. Therefore, both the percentage of oesophageal emptying
Fig. 6. Reduction rate in height and area for the timed barium oesophagogram. Corresponding P-values are shown. The bottom and top of each box represent the ﬁrst and third
quartiles, respectively, and the horizontal band inside the box represents the median. The ends of the whiskers represent the minimum and maximum. Data in parenthesis are
number of the patients analysed.
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groups in the present study.
The question then arises of how relevant these radiological
observations are for the clinical outcome. When symptoms were
longitudinally evaluatedwithin each study group, we observed that
the relative improvement in functional scales, on the OES18 in-
strument, separated the two procedures from each other in
advantage of the Toupet alternative. Originally, it was hypothesised
that the anterior angulation of the gastro-oesophageal junction
induced by the posterior fundic wrap if anything might elicit a
relative obstacle to food transit over the area. Indeed, this might be
of particular relevance for achalasia patients with non-existent
propulsive motor function of the oesophageal body. However, our
present data do not support such an argument. On the contrary, we
propose that the coverage of the entire length of thecardiomyotomy afforded by the anterior wrap may in fact partially
counteract the functional outcome of the complete division of the
sphincter musculature. It therefore seems relevant to reiterate the
argument in favour of the Toupet reconstruction, the construction
of which basically supports the separation of the divided muscle
components from each other. Whether this is an effect that will
become even more apparent over time remains to be studied.
It is difﬁcult to conduct single-institution trials for patients with
achalasia and the current study suffered from slow recruitment of
patients and a small sample size. This background introduces, by
necessity, the risk for type I as well as type II errors. However, it
should be recognised that until now TBO has not been used in a
controlled clinical trial within this ﬁeld, whereby the results corre-
late nicely and plausibly with the clinical outcomes. To date, there
has only been one randomised controlled trial comparing the Dor
Table 4
Postoperative 24-h pH monitoring.
Dor (n ¼ 11) Toupet (n ¼ 13) P value
Percent time pH < 4 in 24-h pH monitoring
Total (%) 0.8 (0e21.0) 1.9 (0e12.2) 0.267
Upright (%) 1.1 (0e15.4) 2.9 (0e19.8) 0.483
Supine (%) 0 (0e35.2) 0 (0e12.3) 0.571
Number of reﬂux episode
Total 3.5 (0e77) 1 (0e44) 0.682
Upright 3 (0e77) 1 (0e44) 0.772
Supine 0 (0e9) 0 (0e3) 0.427
Abnormal acid reﬂux
Total 2 5 0.386
Data are presented as median (range) or the number of patients. ManneWhitney U
tests were used to test the equality between the two medians of the variables. The
Fisher's exact test was used to test the independence between the two groups.
K. Kumagai et al. / International Journal of Surgery 12 (2014) 673e680680and Toupet fundoplication after Heller cardiomyotomy,wherein the
authors foundno statistical difference in the degree of postoperative
dysphagia or reﬂux symptoms between the groups, although there
was a trend towards more reﬂux in the Dor group [8].
In conclusion the results of the present study imply that a partial
posterior fundoplication after cardiomyotomy achieves better
improvement in oesophageal emptying and EORTC QLQ-OES18
functional scale scores compared to an anterior anti-reﬂux proce-
dure. Otherwise no differences between the anti-reﬂux repairs
were noted.
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